Actively Recruiting
Evaluation of a Digital Care Program Combining Neuromodulation and Exercise Therapy for Adults with Episodic or Chronic Migraine
Led by Hinge Health, Inc · Updated on 2026-06-16
140
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a comprehensive digital care program called Enso for Migraine, designed to reduce migraine frequency in adults with episodic or chronic migraine. This program combines an FDA-cleared neuromodulation wearable device with personalized exercise therapy, breathing exercises, and a dedicated care team, aiming to improve migraine management through behavioral awareness and self-management tools. Participants first complete a 28-day baseline period using an electronic diary to log migraine days and compliance. Those meeting criteria then receive 12 weeks of access to the full digital care program via the Hinge Health app. The program includes acute migraine treatment with the neuromodulation device, guided exercise playlists, breathing techniques, migraine trigger tracking, and educational resources supported by a licensed physical therapist and health coach. Throughout the study, participants track migraine occurrences daily with the electronic diary. Researchers measure reductions in monthly migraine days, headache impact, work productivity, acute pain relief, and responder rates. The study lasts approximately 16 weeks, including the baseline and intervention phases, with monitoring of participant adherence and migraine-related outcomes to assess the programs clinical effectiveness.
CONDITIONS
Brief Title
A Comprehensive Digital Care Program for Migraine Management
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
